Hsbc Holdings PLC Biogen Inc. Transaction History

Hsbc Holdings PLC

  • $176 Billion
  • Q3 2025

A detailed history of Hsbc Holdings PLC transactions in Biogen Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 447,518 shares of BIIB stock, worth $73.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
447,518
Previous 443,269 0.96%
Holding current value
$73.7 Million
Previous $55.7 Million 12.61%
% of portfolio
0.04%
Previous 0.03%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$122.68 - $148.84 $521,267 - $632,421
4,249 Added 0.96%
447,518 $62.7 Million
Q2 2025

Aug 13, 2025
SELL
$113.38 - $135.49 $4.62 Million - $5.52 Million
-40,760 Reduced 8.42%
443,269 $55.7 Million
Q1 2025

May 14, 2025
BUY
$133.43 - $153.27 $5.74 Million - $6.59 Million
43,028 Added 9.76%
484,029 $66.2 Million
Q4 2024

Feb 14, 2025
BUY
$146.47 - $191.55 $3.9 Million - $5.1 Million
26,605 Added 6.42%
441,001 $67.4 Million
Q3 2024

Nov 14, 2024
BUY
$189.07 - $236.8 $6.8 Million - $8.52 Million
35,959 Added 9.5%
414,396 $80.3 Million
Q2 2024

Aug 12, 2024
SELL
$190.52 - $236.72 $3.89 Million - $4.83 Million
-20,405 Reduced 5.12%
378,437 $87.7 Million
Q1 2024

May 15, 2024
BUY
$212.02 - $267.71 $15.5 Million - $19.6 Million
73,234 Added 22.49%
398,842 $86 Million
Q4 2023

Feb 12, 2024
BUY
$222.59 - $267.94 $11.8 Million - $14.2 Million
52,974 Added 19.43%
325,608 $84.3 Million
Q3 2023

Nov 13, 2023
SELL
$253.3 - $285.89 $2.75 Million - $3.11 Million
-10,875 Reduced 3.84%
272,634 $70.1 Million
Q2 2023

Aug 11, 2023
BUY
$275.25 - $318.06 $9.2 Million - $10.6 Million
33,429 Added 13.37%
283,509 $80.8 Million
Q1 2023

May 15, 2023
SELL
$256.56 - $292.34 $8.17 Million - $9.31 Million
-31,858 Reduced 11.3%
250,080 $69.5 Million
Q4 2022

Feb 14, 2023
BUY
$252.44 - $306.72 $28.2 Million - $34.3 Million
111,755 Added 65.67%
281,938 $78.1 Million
Q3 2022

Nov 14, 2022
SELL
$194.69 - $268.46 $7.04 Million - $9.7 Million
-36,149 Reduced 17.52%
170,183 $45.4 Million
Q2 2022

Aug 11, 2022
BUY
$187.54 - $223.02 $7.51 Million - $8.94 Million
40,071 Added 24.1%
206,332 $42.4 Million
Q1 2022

May 16, 2022
BUY
$193.77 - $244.14 $1.94 Million - $2.45 Million
10,034 Added 6.42%
166,261 $35.1 Million
Q4 2021

Feb 11, 2022
BUY
$223.92 - $287.77 $89,568 - $115,108
400 Added 0.26%
156,227 $37.5 Million
Q3 2021

Nov 12, 2021
SELL
$282.99 - $369.05 $5.16 Million - $6.73 Million
-18,240 Reduced 10.48%
155,827 $44.3 Million
Q2 2021

Aug 13, 2021
SELL
$259.0 - $414.71 $23 Million - $36.9 Million
-88,967 Reduced 33.82%
174,067 $60.3 Million
Q1 2021

May 14, 2021
SELL
$242.95 - $284.63 $1.68 Million - $1.97 Million
-6,908 Reduced 2.56%
263,034 $73.6 Million
Q4 2020

Feb 25, 2021
BUY
$236.26 - $355.63 $19.1 Million - $28.7 Million
80,718 Added 42.66%
269,942 $66.1 Million
Q4 2020

Feb 12, 2021
SELL
$236.26 - $355.63 $10 Million - $15.1 Million
-42,336 Reduced 18.28%
189,224 $46.3 Million
Q3 2020

Nov 12, 2020
SELL
$264.77 - $305.71 $10.5 Million - $12.1 Million
-39,559 Reduced 14.59%
231,560 $65.7 Million
Q2 2020

Aug 14, 2020
BUY
$258.66 - $342.55 $20.2 Million - $26.7 Million
77,992 Added 40.38%
271,119 $72.5 Million
Q1 2020

May 15, 2020
SELL
$268.85 - $341.04 $40.4 Million - $51.2 Million
-150,229 Reduced 43.75%
193,127 $61 Million
Q4 2019

Feb 14, 2020
BUY
$220.06 - $304.07 $17.2 Million - $23.7 Million
78,036 Added 29.41%
343,356 $101 Million
Q3 2019

Nov 14, 2019
SELL
$217.44 - $243.88 $444,447 - $498,490
-2,044 Reduced 0.76%
265,320 $61.8 Million
Q2 2019

Aug 13, 2019
SELL
$219.29 - $241.72 $9.73 Million - $10.7 Million
-44,384 Reduced 14.24%
267,364 $62.5 Million
Q1 2019

May 15, 2019
BUY
$216.71 - $338.96 $19.9 Million - $31.2 Million
91,994 Added 41.86%
311,748 $73.7 Million
Q4 2018

Feb 13, 2019
SELL
$278.5 - $352.75 $1.07 Million - $1.36 Million
-3,856 Reduced 1.72%
219,754 $66.1 Million
Q3 2018

Nov 13, 2018
BUY
$293.51 - $383.83 $7.75 Million - $10.1 Million
26,419 Added 13.4%
223,610 $79 Million
Q2 2018

Aug 10, 2018
SELL
$257.52 - $306.91 $43 Million - $51.2 Million
-166,909 Reduced 45.84%
197,191 $57.2 Million
Q1 2018

May 11, 2018
BUY
$260.13 - $367.91 $9.14 Million - $12.9 Million
35,143 Added 10.68%
364,100 $99.7 Million
Q4 2017

Feb 14, 2018
SELL
$307.64 - $344.58 $5.16 Million - $5.78 Million
-16,783 Reduced 4.85%
328,957 $105 Million
Q3 2017

Nov 14, 2017
BUY
$281.15 - $329.69 $12 Million - $14.1 Million
42,816 Added 14.13%
345,740 $108 Million
Q2 2017

Aug 14, 2017
BUY
N/A
302,924
302,924 $82.2 Million

Others Institutions Holding BIIB

# of Institutions
1,064
Shares Held
130M
Call Options Held
2.76M
Put Options Held
2.53M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email